Thursday, October 29, 2026 · Today’s edition, 6:30 a.m. ETThu, Oct 29 · 6:30 a.m. editionSign in My Desk 0 EditionsSign in

IDR Strategic Opportunities fund reports $500 million sold

The Oct. 27 Form D lists an indefinite total offering amount and a first sale dated Oct. 9.

$500MReported sold to date in the Oct. 27 Form D

By the Raises & Launches deskOct 28, 2026 · 3:21 a.m. ET3 min read

At a glance

The fund is classified as an other investment fund within the pooled investment fund industry group.
The filing lists the total offering amount as indefinite and names IDR Investment Management LLC as the fund's manager or sponsor.
For allocators, the $500 million reported sold came in the 18 days after the Oct. 9 first sale, in an offering with no stated cap.

IDR Strategic Opportunities Fund LLC reported $500 million sold to date in a Form D filed with the SEC on Oct. 27, with a first sale dated Oct. 9.

The fund is classified as an other investment fund within the pooled investment fund industry group.

The filing lists the total offering amount as indefinite and names IDR Investment Management LLC as the fund's manager or sponsor.

For allocators, the $500 million reported sold came in the 18 days after the Oct. 9 first sale, in an offering with no stated cap.

Reported by the Raises & Launches desk from SEC EDGAR. Published Oct 28, 2026 · 3:21 a.m. ET. Corrections

Real Estate

Invesco prices its redemption queue at 95 cents

The $12.7B ICRE fund offers fee cuts and a discounted tender to avoid a forced sale, pricing the exit before the market prices the buildings.

Interval Funds

Invesco cuts fees 20% and sets tender at 95% NAV

A $2.2 billion redemption queue has Invesco cutting fees 20%, adding $150 million of its own money, and letting shareholders exit at 95 cents on the dollar.

Allocators

Invesco cuts core real estate fees 20% to ease redemptions

A 20% fee cut rewards investors who stay. The tender offer prices exits at 95 cents on the dollar.

Alternatives

Formation Bio raises $600 million for debut drug fund

The vehicle will finance 10 to 15 clinical-stage programs over three to five years, with endowments, hospitals and foundations among its limited partners.